Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

News > Ireland & UK

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2629 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Phico Therapeutics Ltd.. (1/15/19). "Press Release: Phico Therapeutics Appoints Financial Director and Two Non-Executives". Cambridge. 2019-01-15
AstraZeneca plc. (1/7/19). "Press Release: AstraZeneca Announces Organisational Changes". 2019-01-07
Exscientia Ltd.. (1/7/19). "Press Release: Exscientia Initiates Sixth AI Drug Discovery Partnership". 2019-01-07
F2G Ltd.. (1/7/19). "Press Release: F2G Expands Investor Syndicate and Progresses Phase IIb Study for Novel Antifungal". Manchester. 2019-01-07
Exscientia Ltd.. (1/7/19). "Press Release: Exscientia Raises US$26 Million in Series B Financing Round to Accelerate Scaling as the Leading AI Drug Discovery Company". 2019-01-07
Orchard Therapeutics Ltd.. (1/7/19). "Press Release: Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy". Boston & London. 2019-01-07
Immunocore Ltd.. (1/4/19). "Press Release: Immunocore Appoints Bahija Jallal as Chief Executive Officer". Oxford & Conshohocken, PA. 2019-01-04
Nabriva Therapeutics plc. (12/21/18). "Press Release: Nabriva Therapeutics Announces Closing of up to a $75 million Term Loan". Dublin. 2018-12-21
Morphogen-IX Ltd.. (12/20/18). "Press Release: Morphogen-IX Raises £18.4M ($23.2M) in a Series B Financing". Cambridge. 2018-12-20
Nabriva Therapeutics plc. (12/20/18). "Press Release: Nabriva Therapeutics Submits New Drug Applications to U.S. Food and Drug Administration for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults". Dublin. 2018-12-20
Orchard Therapeutics Ltd.. (12/14/18). "Press Release: Orchard Therapeutics and Sirion Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency". Boston, London & Martinsried. 2018-12-14
Orchard Therapeutics Ltd.. (12/13/18). "Press Release: Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California". Boston, MA & London. 2018-12-13
Synthace Ltd.. (12/12/18). "Press Release: Computer Aided Biology Pioneer Synthace Secures $25.6 Million in Series B Funding". London. 2018-12-12
Arix Bioscience plc. (12/11/18). "Press Release: Arix Appoints Dr Christian Schetter as Entrepreneur In Residence (EIR)". London. 2018-12-11
Oxford BioTherapeutics Ltd.. (12/11/18). "Press Release: Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody Platform for Five Bispecific Antibody Programs for up to $450 Million". Shanghai & Oxford. 2018-12-11
Genomics plc. (12/10/18). "Press Release: Genomics plc Today Announces Second Close of Its Series B Financing, Raising a further £8 Million, Bringing the Total Round to £33 million ". Oxford. 2018-12-10
AstraZeneca plc. (12/10/18). "Press Release: AstraZeneca and Cancer Research UK Launch Functional Genomics Centre to Accelerate the Discovery of New Medicines". 2018-12-10
AstraZeneca plc. (12/7/18). "Press Release: Update on the Phase III EAGLE Trial of Imfinzi and Tremelimumab in Advanced Head and Neck Cancer". 2018-12-07
Genomics England Ltd.. (12/5/18). "Press Release: The UK Has Sequenced 100,000 Whole Genomes in the NHS. Pioneering 100,000 Genomes Project Reaches Its Goal and Thanks All Involved". 2018-12-05
GlaxoSmithKline plc. (12/3/18). "Press Release: GSK to Divest Horlicks and other Consumer Healthcare Nutrition Products to Unilever". 2018-12-03
GlaxoSmithKline plc. (12/3/18). "Press Release: GSK Reaches Agreement to Acquire Tesaro, an Oncology Focused Biopharmaceutical Company". London. 2018-12-03
Igem Therapeutics Ltd.. (11/30/18). "Press Release: Igem Therapeutics Announces Final Close of £5 Million Series A Financing Round". London. 2018-11-30
Sygnature Discovery Ltd.. (11/27/18). "Press Release: Sygnature Discovery Establishes US Office in Cambridge, MA". Nottingham & Cambridge, MA. 2018-11-27
Genomics Medicine Ireland Ltd.. (11/27/18). "Press Release: $400 Million Investment Programme Positions Ireland for Global Leadership in Genomic Research and Advanced Life Sciences". 2018-11-27
OMass Therapeutics Ltd.. (11/27/18). "Press Release: OMass Therapeutics Expands Its Senior Leadership Team". 2018-11-27
Immune Regulation Ltd.. (11/26/18). "Press Release: Immune Regulation Announces Positive Results from Phase 1 Clinical Trial of PIN201104". Stevenage. 2018-11-26
Cobra Biologics Ltd.. (11/26/18). "Press Release: Cobra Biologics, Pall Corporation and the Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant to Investigate Continuous Manufacturing for Gene Therapies". Keele & Port Washington, NY & London. 2018-11-26
GlaxoSmithKline plc. (11/26/18). "Press Release: Juluca (dolutegravir/rilpivirine), the First Single Pill, 2-drug Regimen, for the Maintenance Treatment of HIV, Granted Marketing Approval by Japan Ministry of Health, Labour and Welfare". London. 2018-11-26
Oxford BioMedica plc. (11/23/18). "Press Release: Oxford BioMedica Announces New Digital Framework Initiative to Streamline the Production of Next-generation Medicines with Cash Injection from Innovate UK". Oxford. 2018-11-23
Immune Regulation Ltd.. (11/22/18). "Press Release: Peptinnovate Announces Change of Name to Immune Regulation, Strengthening of the Board and Successful Fundraise". 2018-11-22
GlaxoSmithKline plc. (11/22/18). "Press Release: GSK and Kyowa Hakko Kirin Sign Strategic Commercialisation Deal in Japan for Daprodustat, a Potential New Oral Treatment for Anaemia Associated with Chronic Kidney Disease". London. 2018-11-22
F2G Ltd.. (11/22/18). "Press Release: EU Supports F2G Biotech in Austria with EUR 24 Million for Antifungal Research and Innovation". Luxembourg. 2018-11-22
OMass Therapeutics Ltd.. (11/21/18). "Press Release: OMass Therapeutics Announces £14 Million Series A Financing to Build a Pipeline of Proprietary Medicines". Oxford. 2018-11-21
Inflazome Ltd.. (11/19/18). "Press Release: Inflazome Completes €40m ($46m) Series B Financing to Develop NLRP3 Inflammasome Inhibitors to Clinical Proof-of-Concept". Dublin & Cambridge. 2018-11-19
Immunocore Ltd.. (11/19/18). "Press Release: Immunocore to Co-develop IMC-C103C, a T Cell Redirecting Bi-specific Biologic, with Genentech". Oxford & Conshohocken, PA. 2018-11-19
Agilent Technologies Inc.. (11/16/18). "Press Release: Agilent Expands Cell Analysis R&D Capabilities in Ireland. New Facility Incorporates Recently Acquired Luxcel Biosciences". Santa Clara, CA. 2018-11-16
Genomics England Ltd.. (11/15/18). "Press Release: Helomics Partners with Genomics England’s Discovery Forum to Drive Precision Medicine for Ovarian Cancer". 2018-11-15
Goodwin Procter LLC. (11/15/18). "Press Release: Goodwin Adds Life Sciences and Technology Partner Sophie McGrath in London". London. 2018-11-15
Hox Therapeutics Ltd.. (11/13/18). "Press Release: Hox Therapeutics Appoints Karl Keegan as Chief Executive Officer". Guildford, Surrey. 2018-11-13
Consilium Strategic Communications Ltd.. (11/12/18). "Press Release: Alex Harrison Joins Consilium Strategic Communications". London. 2018-11-12
Edinburgh Molecular Imaging Ltd.. (11/8/18). "Press Release: Edinburgh Molecular Imaging Appoints Bernhard Sixt as New Chief Executive Officer". Edinburgh. 2018-11-08
Genomics Medicine Ireland Ltd.. (11/7/18). "Press Release: GMI Genomics Centre Awarded CAP-Accreditation". 2018-11-07
Genomics Medicine Ireland Ltd.. (11/6/18). "Press Release: GMI Appoints Dr. Anne Jones as CEO". 2018-11-06
Nabriva Therapeutics plc. (11/6/18). "Press Release: Nabriva Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights". Dublin. 2018-11-06
AstraZeneca plc. (11/6/18). "Press Release: Divestment of Rights to Alvesco, Omnaris and Zetonna to Covis Pharma". 2018-11-06
Orchard Therapeutics Ltd.. (11/5/18). "Press Release: Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters’ Option". Boston, MA & London. 2018-11-05
Nabriva Therapeutics plc. (11/1/18). "Press Release: Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous Contepo to Treat Complicated Urinary Tract Infections". Dublin. 2018-11-01
Cobra Biologics Ltd.. (10/30/18). "Press Release: Cobra Biologics and the University of Leeds Collaborate in BioProNET Funded Project". Keele & Leeds. 2018-10-30
DefiniGen Ltd.. (10/30/18). "Press Release: DefiniGen Licenses Broad Institute CRISPR-Cas9 Gene Editing Technology for Optimized Metabolic Disease Drug Development". Cambridge. 2018-10-30
Edinburgh Molecular Imaging Ltd.. (10/29/18). "Press Release: Edinburgh Molecular Imaging Ltd Appoints New Chairman". Edinburgh. 2018-10-29
Immunocore Ltd.. (10/26/18). "Press Release: Immunocore CEO Andrew Hotchkiss Appointed to the Board of the BIA". Oxford & Conshohocken, PA. 2018-10-26
Microbiotica Ltd.. (10/24/18). "Press Release: Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital Fund". Cambridge. 2018-10-24
NodThera Ltd.. (10/23/18). "Press Release: NodThera Announces the Appointment of Alison Strutt PhD as Head of Finance & Operations, the Launch of Its New Corporate Office in Boston and the Opening of Its Laboratory in Seattle". Cambridge, Boston, MA & Se 2018-10-23
Medicines Discovery Catapult, The. (10/22/18). "Press Release: Overcoming Bottlenecks in Early Drug Discovery with the Power of Sound. Medicines Discovery Catapult and AstraZeneca Collaborate to Unlock the Potential of Acoustic Mist Ionisation Mass Spect 2018-10-22
Randox Laboratories Ltd.. (10/16/18). "Press Release: Randox Collaboration with Centre for Personalised Medicine is Officially Launched". 2018-10-16
Arcis Biotechnology Ltd.. (10/16/18). "Press Release: Arcis Biotechnology and Teleflex Sign License Agreement". Daresbury. 2018-10-16
MeiraGTx Holdings plc. (10/16/18). "Press Release: MeiraGTx Enters Collaboration with Johnson & Johnson Innovation to Develop Regulatable Gene Therapy Treatment using MeiraGTx Riboswitch Technology". London & New York, NY. 2018-10-16
ERS Genomics Ltd.. (10/16/18). "Press Release: ERS Genomics and Syngulon Sign License Agreement on CRISPR/Cas9 Genome Editing Patents for Industrial Applications". Dublin & Seraing. 2018-10-16
F-Star Biotechnology Ltd.. (10/15/18). "Press Release: F-star Appoints Dr Eliot Forster as Chief Executive Officer". Cambridge. 2018-10-15
Randox Laboratories Ltd.. (10/12/18). "Press Release: Researching the Evidence Investigator". 2018-10-12
Owlstone Medical. (10/10/18). "Press Release: Owlstone Medical Appoints Dr Richard A Yost to Scientific Advisory Board". Cambridge. 2018-10-10
Roslin Cell Therapies (RoslinCT). (10/10/18). "Press Release: RoslinCT and Reprocell Awarded £1.2 Million Project from Innovate UK for Clinical-grade Stem Cell Production". Edinburgh & Glasgow. 2018-10-10
Avacta Group plc. (10/10/18). "Press Release: Avacta Agrees Affimer Reagent Licensing Deal with New England Biolabs (NEB)". Edinburgh & Glasgow. 2018-10-10
Oxford Nanopore Technologies Ltd.. (10/10/18). "Press Release: MinIT Is Out – an Analysis and Device Control Accessory to Enable Powerful, Real-time DNA/RNA Sequencing by Anyone, Anywhere". 2018-10-10
MeiraGTx Holdings plc. (10/9/18). "Press Release: MeiraGTx Announces Acquisition of Vector Neurosciences, Gains Phase 2 Gene Therapy Program for Parkinson’s Disease". London & New York. 2018-10-09
ERS Genomics Ltd.. (10/4/18). "Press Release: GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Fujisawa & Dublin. 2018-10-04
ERS Genomics Ltd.. (10/4/18). "Press Release: Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Fujisawa & Dublin. 2018-10-04
Arcis Biotechnology Ltd.. (10/2/18). "Press Release: Arcis Biotechnology Raises £1.25 Million (USD $1.63 Million) Funding and Opens further £0.5 Million Investment Opportunity through Capital Cell". Daresbury. 2018-10-02
Evonetix Ltd.. (10/1/18). "Press Release: Evonetix Partner with LioniX International to Enable DNA Synthesis at Scale". Cambridge & Enschede. 2018-10-01
Arix Bioscience plc. (10/1/18). "Press Release: Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio". London. 2018-10-01
Owlstone Medical Ltd.. (10/1/18). "Press Release: Owlstone Medical Completes $50 Million USD (c.£38 Million GBP) Financing Round". Cambridge. 2018-10-01
Tusk Therapeutics Ltd.. (9/28/18). "Press Release: Tusk Therapeutics to Be Acquired by Roche". Stevenage. 2018-09-28
Clyde Biosciences Ltd.. (9/27/18). "Press Release: Major International FDA-led Study Confirms CellOptiq High Content Assay as Leading in vitro Platform to Assess Cardiotoxicity in New Drugs". Motherwell. 2018-09-27
Nightstar Therapeutics plc. (9/27/18). "Press Release: Nightstar Announces Pricing of Public Offering". Waltham, MA & London. 2018-09-27
TTP Labtech Ltd.. (9/27/18). "Press Release: Battery Ventures Acquires TTP Labtech Limited, Global Leader in Liquid Handling & Sample Management Technologies". Cambridge. 2018-09-27
Nightstar Therapeutics plc. (9/25/18). "Press Release: Nightstar Announces Proposed Public Offering of American Depositary Shares". Waltham, MA & London. 2018-09-25
NodThera Ltd.. (9/24/18). "Press Release: NodThera Announces the Appointment of Adam Keeney PhD as President and Chief Executive Officer". Cambridge & Boston, MA. 2018-09-24
Domainex Ltd.. (9/20/18). "Press Release: Domainex Appoints Dr Trevor Perrior as Chief Executive Officer". Cambridge. 2018-09-20
Addex Therapeutics S.A.. (9/20/18). "Press Release: Addex ADX10061 Receives £1.2 million Funding for Manufacture and Investigator Led Clinical Studies as Part of the Tools for Human Drug and Brain Research (THuNDR2) Initiative from the Wellcome Trust". G 2018-09-20
Tissue Solutions Ltd.. (9/20/18). "Press Release: Tissue Solutions Ltd Expands Service Offering with HistologiX Ltd Acquisition". 2018-09-20
Oxford Genetics Ltd.. (9/20/18). "Press Release: Oxford Genetics Extends Its CRISPR Gene Editing Technology License Agreement from ERS Genomics to Support Its Growth Internationally". Oxford. 2018-09-20
Medicines Discovery Catapult, The. (9/19/18). "Press Release: Novel Deep Learning Drug Discovery Platform Gets £1 Million Innovation boost. Optibrium, Intellegens and Medicines Discovery Catapult Awarded Funding to Apply Machine Learning in Drug Discover 2018-09-19
Premaitha Health plc. (9/19/18). "Press Release: Legal Settlement and Licence Agreement with Illumina". Manchester. 2018-09-19
Sphere Fluidics Ltd.. (9/17/18). "Press Release: Sphere Fluidics Introduces New Cyto-Mine Studio Software Suite". Cambridge. 2018-09-17
Metrion Biosciences Ltd.. (9/17/18). "Press Release: Metrion Biosciences Makes Senior Appointments to Strengthen Its Drug Discovery Leadership tTeam". Cambridge. 2018-09-17
Cancer Research UK. (9/17/18). "Press Release: London Biotherapeutics Powerhouse Launched by Cancer Research UK". 2018-09-17
Virion Biotherapeutics Ltd.. (9/17/18). "Press Release: Virion Appoints Vanessa King as President & CEO and Isabel Najera as CSO". London. 2018-09-17
Horizon Discovery Group plc. (9/14/18). "Press Release: Horizon Discovery Edit-R crRNA Libraries Adopted by AstraZeneca as Part of Its Functional Genomics Discovery Platform". Cambridge. 2018-09-14
Novacyt S.A.. (9/13/18). "Press Release: Novacyt Partners with Applied Microarrays in Assay Design". Paris & Camberley. 2018-09-13
University of Oxford. (9/12/18). "Press Release: Novo Nordisk Research Centre Opens in Oxford". 2018-09-12
Arix Bioscience plc. (9/12/18). "Press Release: Arix Bioscience plc Announces Board Changes, Appointment of Arthur Pappas to the Board of Directors, David U’Prichard to Retire from Board". London. 2018-09-12
University of Glasgow. (9/11/18). "Press Release: Cutting-edge Electron Microscope Revealed at Opening of New £5m Structural Biology Centre". 2018-09-11
Cell and Gene Therapy Catapult, The. (9/11/18). "Press Release: Stevenage Cell and Gene Therapy Catapult Centre Gets Green Light to Make New Cell and Gene Therapies". 2018-09-11
Optibrium Ltd.. (9/11/18). "Press Release: Optibrium and Intellegens Collaborate to Apply Novel Deep Learning Methods to Drug Discovery". Cambridge. 2018-09-11
Crescendo Biologics Ltd.. (9/11/18). "Press Release: Crescendo Biologics Strengthens its Management with the Appointment of Dr Pavel Pisa as Chief Medical Officer". Cambridge. 2018-09-11
Arecor Ltd.. (9/10/18). "Press Release: Arecor Secures £6m Investment for the Clinical Development of Its Diabetes Speciality Pharma Portfolio". Cambridge. 2018-09-10
F-Star Biotechnology Ltd.. (9/10/18). "Press Release: F-star Appoints Nessan Bermingham as Chairman of its Board of Directors". Cambridge. 2018-09-10
BTG plc. (9/7/18). "Press Release: BTG plc Acquires Novate Medical Ltd.". 2018-09-07
Adaptimmune Therapeutics plc. (9/5/18). "Press Release: Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2018-09-05
Optibrium Ltd.. (9/4/18). "Press Release: Optibrium and Enamine Collaboration Extends Commercial Compound Database Access for StarDrop Users". Cambridge & Kiev. 2018-09-04
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top